| Alg10b |
Mus musculus |
|
Alg10b is differentially expressed in 38 experiments [29 up/34 dn]: 12 organism parts: liver [0 up/2 dn], pituitary gland [1 up/0 dn], ...; 7 cell types: Sertoli cell [1 up/0 dn], spermatid [0 up/1 dn], ...; 8 compound treatments, 13 developmental stages, 6 genotypes and 5 other conditions. |
| AU045404, Alg10b |
|
ALG10B (Homo sapiens)
tag-179 (Caenorhabditis elegans)
DIE2 (Saccharomyces cerevisiae)
Alg10 (Drosophila melanogaster)
(Compare orthologs)
|
|
|
| Alpha-1, 2 glucosyltransferase Alg10, Glycosyltransferase, ALG10 |
|
|
| integral to membrane, plasma membrane, potassium channel regulator activity, transferase activity, transferring hexosyl groups |
|
|
|
Q3UGP8
Q3UPY7
|
|
|
|
ENSMUSG00000075470
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Control
|
Compound treatment |
|
|
Wild_type
|
Genotype |
|
|
Liver
|
Organism part |
|
|
Adult
|
Developmental stage |
|
|
Embryo
|
Developmental stage |
|
|
E14.5
|
Developmental stage |
|
|
Control
|
Infection |
|
|
Mycobacterium tuberculosis
|
Infection |
|
|
Sertoli cell
|
Cell type |
|
|
Spermatid
|
Cell type |
|
|
Spermatogonium
|
Cell type |
|
|
Pituitary gland
|
Organism part |
|
|
1-cell
|
Developmental stage |
|
|
Spermatocyte
|
Cell type |
|
|
8-cell
|
Developmental stage |
|
|
Control - PBS
|
Compound treatment |
|
|
Allergen
|
Compound treatment |
|
|
ATF3(-/-)
|
Genotype |
|
|
CBA/CaJ
|
Strain or line |
|
|
C57BL/6J
|
Strain or line |
|
|
Constant darkness
|
Light |
|
|
12 h light:12 h dark
|
Light |
|
|
Colon
|
Organism part |
|
|
Partial hepatectomy
|
Injury |
|
|
Submandibular gland
|
Organism part |
|
|
Periaqueductal gray
|
Organism part |
|
|
Kidney
|
Organism part |
|
|
Pam3CSK4
|
Compound treatment |
|
|
E16.5
|
Developmental stage |
|
|
E12
|
Developmental stage |
|
|
E8.5
|
Developmental stage |
|
|
Skeletal muscle
|
Organism part |
|
|
E13.5
|
Developmental stage |
|
|
E15.5
|
Developmental stage |
|
|
R848
|
Compound treatment |
|
|
2-cell
|
Developmental stage |
|
|
Resting bulk splenocytes
|
Cell type |
|
|
HRas-v12 transgene induced
|
Genotype |
|
|
Actinomycin D
|
Compound treatment |
|
|
Gastrocnemius muscle
|
Organism part |
|
|
Extraocular muscle
|
Organism part |
|
|
Oocyte
|
Developmental stage |
|
|
SCD1-/-
|
Genotype |
|
|
Microglial cell
|
Cell type |
|
|
Hippocampus
|
Organism part |
|
|
Blastocyst
|
Developmental stage |
|
|
Bmal1-/-
|
Genotype |
|
|
Activated natural killer cells
|
Cell type |
|
|
Interleukin-2
|
Compound treatment |
|
|
Hypothalamus
|
Organism part |
|
|
Bed nucleus of the stria termi...
|
Organism part |
|
|
Dinitrofluorobenzene
|
Compound treatment |
|
|
Pkd1 -/-
|
Genotype |
|
|
Control diet
|
Growth condition |
|
|
Very low fat, high carbohydrat...
|
Growth condition |
|
|
|
|
|
Processing time: 0.066 secs.